Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment
Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.